Akebia Therapeutics Inc. experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $2.08 on 03/22/24, while the lowest price for the same period was registered at $0.49 on 04/05/23.
52-week price history of AKBA Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Akebia Therapeutics Inc.’s current trading price is 4.33% away from its 52-week high, while its distance from the 52-week low is 342.77%. The stock’s price range during this period has spanned from $0.49 to $2.08. In the Healthcare sector, the Akebia Therapeutics Inc.’s shares surpassed a trading volume of approximately 7.85 million for the day, which was noticeably higher compared to the average daily volume of 9.2.75 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Akebia Therapeutics Inc. (AKBA) has experienced a quarterly rise of 80.83% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 454.33M and boasts a workforce of 167 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.35, with a change in price of +1.33. Similarly, Akebia Therapeutics Inc. recorded 2,224,218 in trading volume during the last 100 days, posting a change of +158.30%.
AKBA Stock Stochastic Average
Today, Akebia Therapeutics Inc.’s raw stochastic average for the past 50 days stands at 92.63%, indicating a rise from the raw stochastic average of the last 20 days, which was 92.22%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 90.63% and 83.81% respectively.
AKBA Stock Price Performance Analysis
The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. This year’s metric has recorded a Price increase of 75.00%. However, over the past six months, we’ve seen a weaker performance of 87.07%. The price of AKBA fallen by 56.12% over the last 30 days. And in the last five days, it has surged by 27.65%.
